ACROBiosystems社 Overexpression Cell Lines
The generation and maintenance of immune responses are controlled by both co-stimulatory and co-inhibitory signals through T cell co-receptors. Many co-stimulatory belong to the B7 ligand family or the tumor necrosis factor receptor superfamily. Immunotherapy has long been considered an important cancer treatment option, and immune checkpoint inhibitors (ICIs) targeting PD-1, PD-L1, and CTLA-4 have revolutionized cancer treatment. Nowadays, proven agonistic or antagonistic monoclonal antibodies targeting co-receptors have the potential to enhance immunity.
To meet the drug research and development, ACROBiosystems has developed a series of overexpressed stable cell lines for agonistic targets such as 4-1BB/4-1BBL/OX40/OX40L, which can screen high-affinity antibodies that bind to immune checkpoint proteins in cell-based assays. |
|||||||||||||||
Highlight Features
★ Bioactivity of overexpression cell-lines verified by FACS ★ 15 passages stability verified ★ Robust cell line with high protein productivity |
|||||||||||||||
Product List
*Click on the Cat. No. to view Assay Data and request for Free Protocol *Click on the Molecular name to view all related product lists |
|||||||||||||||
Fount of Information は、新商品、新規取扱メーカーなどの情報をいち早く紹介するコンテンツです。情報発信のスピードを重視しているコンテンツのため、現時点で法規制や取り扱いを確認できていない商品、定価を設定できていない商品があります。ご要望やご照会を受けた商品について、法令整備や在庫の充実を図ります。